Delivering monitored ketamine infusions, exploring additional depression treatment options

People who continue to experience significant depressive symptoms after trying standard treatments may ask their clinician about other options, particularly when symptoms affect their ability to function at home, at work, or in relationships. Intravenous (IV) ketamine is delivered through a vein in a supervised clinical setting and may be considered for some adults with treatment-resistant depression. Its use for depression and PTSD is generally off-label in the United States, and the evidence and suitability differ by condition, so a clinician should explain the rationale and limitations before treatment.

How It Works

An IV ketamine session typically involves the following:

  • Intravenous Infusion: Ketamine is delivered through an IV line at a dose determined by the treating clinician.
  • Clinical Monitoring: Healthcare professionals monitor relevant vital signs and the patient’s response during and after the infusion.
  • Observation for Temporary Effects: Patients may experience changes in perception, dizziness, nausea, or dissociation during treatment.
  • Review of Symptom Response: The clinician evaluates how symptoms and side effects change across the treatment course.
  • Integration With Mental Health Care: Ketamine may be considered as part of a broader treatment plan rather than a replacement for all other mental health support.

Potential Benefits and Important Considerations

Research suggests IV ketamine can produce relatively rapid reductions in depressive symptoms for some people with treatment-resistant depression, but the duration of benefit varies and continued treatment may not be appropriate for everyone. Evidence for its use in PTSD is less certain, and it is not an FDA-approved treatment specifically for PTSD. Possible adverse effects, medical risks, and the off-label nature of treatment should be discussed before a patient decides whether to proceed.

What to Expect

Treatment takes place in person, and patients should expect to remain at the clinic during the infusion and the post-treatment observation period. Tripple C Inc.’s reference describes a three-week full course, but the exact number of infusions, their frequency, and whether further treatment is recommended must be confirmed with the provider and determined by clinical judgment. Patients should arrange transportation home and follow the clinic’s instructions about driving, medication use, and activity after treatment.

Get Support in Understanding Your Concerns

If attention, memory, or learning difficulties have been affecting your daily routine, reach out. to discuss what you’ve been experiencing. You can ask questions, understand your assessment options, and decide what feels like the appropriate next step.